Bora CDMO Bora CDMO

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Find Radio Compass News for Bexagliflozin

    Client Email Product

    Bexagliflozin

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    PRICE INFORMATION

    DOSSIERs // Finished Dosage Formulations

    PATENTS

    DIGITAL CONTENT

    PharmaCompass
    Product SearchProduct Search
    API SUPPLIERS
    API Suppliers

    API Suppliers

    7
    US DMFs Filed

    US DMFs Filed

    1
    CEP/COS Certifications

    CEP/COS Certifications

    0

    JDMFs Filed

    JDMFs Filed

    0

    Other Certificates

    Other Certificates

    2
    Other Suppliers

    Other Suppliers

    4
    API REF. PRICE (USD / KG)
    6,252

    API Market Place

    0

    INTERMEDIATES

    0

    DOSSIERS // FDF
    USA (Orange Book)

    USA (Orange Book)

    1
    Europe

    Europe

    0

    Canada

    Canada

    0

    Australia

    Australia

    0

    South Africa

    South Africa

    0

    Uploaded Dossiers

    Uploaded Dossiers

    0

    GLOBAL SALES (USD Million)

    U.S. Medicaid

    0

    Annual Reports

    0

    FDF Market Place

    0

    EXCIPIENTS

    0

    PATENTS & EXCLUSIVITIES

    USFDA Orange Book Patents

    6

    USFDA Exclusivities

    1
    DIGITAL CONTENT

    Blog #PharmaFlow

    1

    News

    9
    REF STANDARD

    EDQM

    0

    USP

    0

    JP

    0

    Other Listed Suppliers

    0

    SERVICES

    0

    Full View ScreenFull Screen View
    IPC Secures Distribution Rights to Independent Retail Pharmacies for BRENZAVVY
    IPC Secures Distribution Rights to Independent Retail Pharmacies for BRENZAVVY

    https://www.prnewswire.com/news-releases/independent-pharmacy-cooperative-ipc-secures-exclusive-distribution-rights-to-independent-retail-pharmacies-for-brenzavvy-bexagliflozin-with-theracosbio-partnership-302050765.html

    PR NEWSWIRE
    01 Feb 2024
    Share Share
    CV Safety Profile of TheracosBio’s BRENZAVVY Confirmed in Research Published
    CV Safety Profile of TheracosBio’s BRENZAVVY Confirmed in Research Published

    https://www.businesswire.com/news/home/20240108590290/en

    BUSINESSWIRE
    08 Jan 2024
    Share Share
    TheracosBio, IPC Announce Partnership to Make BRENZAVVY Available
    TheracosBio, IPC Announce Partnership to Make BRENZAVVY Available

    https://www.businesswire.com/news/home/20231220345201/en

    BUSINESSWIRE
    20 Dec 2023
    Share Share
    TheracosBio and SmithRx Collaborate to Offer Approved Diabetes Drug Brenzavvy
    TheracosBio and SmithRx Collaborate to Offer Approved Diabetes Drug Brenzavvy

    https://www.businesswire.com/news/home/20230817908329/en

    BUSINESSWIRE
    17 Aug 2023
    Share Share
    TheracosBio Announces Publication of Data on the Safety of Brenzavvy
    TheracosBio Announces Publication of Data on the Safety of Brenzavvy

    https://www.businesswire.com/news/home/20230804374538/en

    BUSINESSWIRE
    04 Aug 2023
    Share Share
    TheracosBio Announces Commercial Availability of Brenzavvy
    TheracosBio Announces Commercial Availability of Brenzavvy

    https://www.businesswire.com/news/home/20230713335052/en

    BUSINESSWIRE
    13 Jul 2023
    Share Share
    Piramal Supports Theracosbio With Integrated Drug Substance Program For Bexagliflozin
    Piramal Supports Theracosbio With Integrated Drug Substance Program For Bexagliflozin

    https://www.prnewswire.com/news-releases/piramal-pharma-solutions-supports-theracosbio-with-integrated-drug-substancedrug-product-program-for-bexagliflozin-301785622.html

    PR NEWSWIRE
    30 Mar 2023
    Share Share
    TheracosBio wins FDA green light for new diabetes med
    TheracosBio wins FDA green light for new diabetes med

    https://www.fiercepharma.com/pharma/theracosbio-green-light-another-sglt2-inhibitor-wades-type-2-diabetes-arena

    Fraiser Kansteiner FIERCE PHARMA
    24 Jan 2023
    Share Share
    Elanco Announces FDA Approval of Bexacat (bexagliflozin tablets)
    Elanco Announces FDA Approval of Bexacat (bexagliflozin tablets)

    https://www.businesswire.com/news/home/20221209005431/en

    BUSINESSWIRE
    09 Dec 2022
    Share Share
    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    euroapi-m-2024-04-29

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Access Virtual Booth

    Contact Supplier

    View Presentation

    Post Enquiry
    POST ENQUIRY

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search